In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Entellus Medical Inc. (NASDAQ:ENTL) reported that Discovery Group I, Llc. has picked up 1,418,715 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Discovery Group I, Llc. to a total of 1,418,715 representing a 6.5% stake in the company.
For those not familiar with the company, Entellus Medical, Inc. is a medical technology company. The Company is focused on the design, development and commercialization of products for the minimally invasive treatment of patients who are suffering from chronic sinusitis. The Company’s XprESS family of products is used by ear, nose and throat (ENT) physicians to treat patients with symptomatic inflammation of the nasal sinuses by opening narrowed or obstructed sinus drainage pathways using balloon sinus dilation. The Company’s XprESS family of products is used to treat patients with inflammation of the frontal, ethmoid, sphenoid and maxillary sinuses. Its XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The Company’s PathAssist tools provide ENT physicians with a way to confirm sinus location and XprESS device placement. Its FocESS Sinuscopes provide ENT physicians with a solution for endoscopic visualization during a sinus procedure.
A glance at Entellus Medical Inc. (NASDAQ:ENTL)’s key stats reveals a current market capitalization of 286.30 million based on 21.88 Million shares outstanding and a price at last close of $13.32 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-02-03, Split picked up 352,941 at a purchase price of $17.00. This brings their total holding to 3,156,731 as of the date of the filing.
On the sell side, the most recent transaction saw Essex unload 16,521 shares at a sale price of $17.00. This brings their total holding to 91,808.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Entellus Medical Inc. (NASDAQ:ENTL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.